Skip to main navigation
Skip to search
Skip to main content
WashU Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Research Profiles
Home
Profiles
Research units
Research output
Rheumatoid arthritis: Treatment of newly diagnosed disease
David N. Lortscher
, Richard D. Brasington
Division of Rheumatology
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Rheumatoid arthritis: Treatment of newly diagnosed disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Rheumatoid Arthritis
100%
Disease-modifying Antirheumatic Drugs (DMARDs)
100%
Newly Diagnosed
100%
Methotrexate
100%
Rheumatoid Arthritis Treatment
100%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
66%
Folic Acid
66%
Disease Progression
33%
Functional Impairment
33%
Inflammation
33%
Initial Dose
33%
Corticosteroids
33%
Severe Symptoms
33%
Drug Therapy
33%
Rheumatologists
33%
Sulfasalazine
33%
Hydroxychloroquine
33%
Leflunomide
33%
Short-term Use
33%
Inflammatory Manifestations
33%
Well Tolerated
33%
Accurate Assessment
33%
Medicine and Dentistry
Rheumatoid Arthritis
100%
Inflammatory Arthritis
100%
Diseases
100%
Methotrexate
75%
Nonsteroid Antiinflammatory Agent
50%
Folic Acid
50%
Disease-Modifying Antirheumatic Drug
50%
Drug Therapy
25%
Disease Exacerbation
25%
Functional Disease
25%
Salazosulfapyridine
25%
Hydroxychloroquine
25%
Leflunomide
25%
Disease Modifying Antirheumatic Drug
25%
Inflammation
25%
Corticosteroid
25%
Oral
25%
Disability
25%
Nursing and Health Professions
Leflunomide
25%
Pharmacology, Toxicology and Pharmaceutical Science
Disability
25%